<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id>
<journal-title-group>
<journal-title>PLOS Computational Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1010406</article-id>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-21-02185</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care facilities</subject><subj-group><subject>Hospitals</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>Europe</subject><subj-group><subject>European Union</subject><subj-group><subject>United Kingdom</subject><subj-group><subject>England</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Pandemics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Forecasting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Forecasting</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Medical conditions</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>COVID 19</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Medical conditions</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Nosocomial infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care facilities</subject><subj-group><subject>Hospitals</subject><subj-group><subject>Intensive care units</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immunity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immunity</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>EpiBeds: Data informed modelling of the COVID-19 hospital burden in England</article-title>
<alt-title alt-title-type="running-head">EpiBeds: Data informed modelling of the COVID-19 hospital burden in England</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8433-4010</contrib-id>
<name name-style="western">
<surname>Overton</surname>
<given-names>Christopher E.</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Pellis</surname>
<given-names>Lorenzo</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9938-8452</contrib-id>
<name name-style="western">
<surname>Stage</surname>
<given-names>Helena B.</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0250-4555</contrib-id>
<name name-style="western">
<surname>Scarabel</surname>
<given-names>Francesca</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8530-0464</contrib-id>
<name name-style="western">
<surname>Burton</surname>
<given-names>Joshua</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fraser</surname>
<given-names>Christophe</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
<xref ref-type="aff" rid="aff010"><sup>10</sup></xref>
<xref ref-type="aff" rid="aff011"><sup>11</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hall</surname>
<given-names>Ian</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff012"><sup>12</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>House</surname>
<given-names>Thomas A.</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
<xref ref-type="aff" rid="aff013"><sup>13</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jewell</surname>
<given-names>Chris</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<xref ref-type="aff" rid="aff014"><sup>14</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7107-1656</contrib-id>
<name name-style="western">
<surname>Nurtay</surname>
<given-names>Anel</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Pagani</surname>
<given-names>Filippo</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff015"><sup>15</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lythgoe</surname>
<given-names>Katrina A.</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
<xref ref-type="aff" rid="aff016"><sup>16</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Mathematics, University of Manchester, Manchester United Kingdom</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Clinical Data Science Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Joint UNIversities Pandemic and Epidemiological Research, https://maths.org/juniper/. Cambridge, United Kingdom</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Infectious Disease Modelling, All Hazards Intelligence, UK Health Security Agency, London, United Kingdom</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Alan Turing Institute, London, United Kingdom</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>The Humboldt University of Berlin, Berlin, Germany</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>The University of Potsdam, Potsdam, Germany</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Faculty of Biology Medicine and Health, Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, United Kingdom</addr-line></aff>
<aff id="aff009"><label>9</label> <addr-line>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom</addr-line></aff>
<aff id="aff010"><label>10</label> <addr-line>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom</addr-line></aff>
<aff id="aff011"><label>11</label> <addr-line>Wellcome Sanger Institute, Cambridge, United Kingdom</addr-line></aff>
<aff id="aff012"><label>12</label> <addr-line>Emergency Preparedness, Health Protection Division, UK Health Security Agency, London, United Kingdom</addr-line></aff>
<aff id="aff013"><label>13</label> <addr-line>IBM Research, Hartree Centre, Daresbury, United Kingdom</addr-line></aff>
<aff id="aff014"><label>14</label> <addr-line>CHICAS, Lancaster Medical School, Lancaster University, Lancaster, United Kingdom</addr-line></aff>
<aff id="aff015"><label>15</label> <addr-line>MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom</addr-line></aff>
<aff id="aff016"><label>16</label> <addr-line>Department of Biology, University of Oxford, Oxford, United Kingdom</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Struchiner</surname>
<given-names>Claudio José</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Fundação Getúlio Vargas: Fundacao Getulio Vargas, BRAZIL</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">christopher.overton@manchester.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>6</day>
<month>9</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<month>9</month>
<year>2022</year>
</pub-date>
<volume>18</volume>
<issue>9</issue>
<elocation-id>e1010406</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>7</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Overton et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pcbi.1010406"/>
<abstract>
<p>The first year of the COVID-19 pandemic put considerable strain on healthcare systems worldwide. In order to predict the effect of the local epidemic on hospital capacity in England, we used a variety of data streams to inform the construction and parameterisation of a hospital progression model, EpiBeds, which was coupled to a model of the generalised epidemic. In this model, individuals progress through different pathways (e.g. may recover, die, or progress to intensive care and recover or die) and data from a partially complete patient-pathway line-list was used to provide initial estimates of the mean duration that individuals spend in the different hospital compartments. We then fitted EpiBeds using complete data on hospital occupancy and hospital deaths, enabling estimation of the proportion of individuals that follow the different clinical pathways, the reproduction number of the generalised epidemic, and to make short-term predictions of hospital bed demand. The construction of EpiBeds makes it straightforward to adapt to different patient pathways and settings beyond England. As part of the UK response to the pandemic, EpiBeds provided weekly forecasts to the NHS for hospital bed occupancy and admissions in England, Wales, Scotland, and Northern Ireland at national and regional scales.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>COVID-19, the disease caused by SARS-CoV-2, leads to a high proportion of cases requiring admission to hospital. Coupled with the high burden of infections worldwide, this put substantial pressure on healthcare systems. To enable public health systems to cope with the high levels of demand, forecasting models are vital. These models enable public health managers to plan their workloads accordingly. Here, we developed EpiBeds, which combines an epidemic model with a model for patient flow through hospitals. By fitting this model to data from England, EpiBeds has been used to provide short-term forecasts of hospital admissions and bed demand weekly throughout the COVID-19 pandemic. In this paper, we describe the motivation behind the structure of EpiBeds, how the model is fitted to data, and report the estimates of the key parameters throughout the pandemic. We then evaluate the performance of EpiBeds by comparing generated forecasts to future data points, finding good agreement between the forecasts and data.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response</institution>
</funding-source>
<principal-award-recipient>
<name name-style="western">
<surname>Hall</surname>
<given-names>Ian</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Wellcome Trust and the Royal Society</institution>
</funding-source>
<award-id>202562/Z/16/Z</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Pellis</surname>
<given-names>Lorenzo</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100010269</institution-id>
<institution>Wellcome Trust</institution>
</institution-wrap>
</funding-source>
<award-id>219992/Z/19/Z</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8530-0464</contrib-id>
<name name-style="western">
<surname>Burton</surname>
<given-names>Joshua</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
<institution>Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>MR/V038613/1</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Jewell</surname>
<given-names>Chris</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000266</institution-id>
<institution>Engineering and Physical Sciences Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>EP/W011840/1</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Jewell</surname>
<given-names>Chris</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award006">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000266</institution-id>
<institution>Engineering and Physical Sciences Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>EP/R018561/1</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Jewell</surname>
<given-names>Chris</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award007">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100004440</institution-id>
<institution>Wellcome Trust</institution>
</institution-wrap>
</funding-source>
<award-id>UNS73114</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Jewell</surname>
<given-names>Chris</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award008">
<funding-source>
<institution>Royal Society</institution>
</funding-source>
<award-id>INF\R2\180067</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>House</surname>
<given-names>Thomas A.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award009">
<funding-source>
<institution>UKRI</institution>
</funding-source>
<award-id>MR/V038613/1</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8433-4010</contrib-id>
<name name-style="western">
<surname>Overton</surname>
<given-names>Christopher E.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award010">
<funding-source>
<institution>Wellcome Trust and the Royal Society</institution>
</funding-source>
<award-id>107652/Z/15/Z</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Lythgoe</surname>
<given-names>Katrina A.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award011">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100007421</institution-id>
<institution>Li Ka Shing Foundation</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<name name-style="western">
<surname>Lythgoe</surname>
<given-names>Katrina A.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award012">
<funding-source>
<institution>National Institute for Health Research Policy Research Programme in Operational Research (OPERA)</institution>
</funding-source>
<principal-award-recipient>
<name name-style="western">
<surname>Hall</surname>
<given-names>Ian</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>I.H. is supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response. L.P., H.B.S. and C.E.O. are funded by the Wellcome Trust and the Royal Society (grant no. 202562/Z/16/Z). J.B. was supported by a Wellcome Trust Four-Year PhD Studentship in Basic Science (219992/Z/19/Z). C.J. is funded by the MRC (MR/V038613/1), EPSRC (EP/W011840/1, EP/R018561/1), and Wellcome (UNS73114). T.A.H. is supported by the Royal Society (grant no. INF\R2\180067). C.E.O., L.P., I.H., T.A.H. and F.S. are supported by the UKRI through the JUNIPER modelling consortium [grant number MR/V038613/1]. K.A.L. is funded by the Wellcome Trust and The Royal Society (107652/Z/15/Z) and the Li Ka Shing Foundation. I.H. is supported by the National Institute for Health Research Policy Research Programme in Operational Research (OPERA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="5"/>
<page-count count="20"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2022-09-16</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>Code for simulating the EpiBeds model is available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/OvertonC/EpiBeds" xlink:type="simple">https://github.com/OvertonC/EpiBeds</ext-link>. The data used were provided through a data sharing agreement, and unfortunately cannot be provided. Data similar to the SITREP and CPNS sources are available at, though with slightly different data definitions, are available at: <ext-link ext-link-type="uri" xlink:href="https://coronavirus.data.gov.uk/details/download" xlink:type="simple">https://coronavirus.data.gov.uk/details/download</ext-link>.</meta-value>
</custom-meta>
<custom-meta id="outbreaks">
<meta-name>Outbreaks</meta-name>
<meta-value>COVID-19</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>1. Introduction</title>
<p>An important component of the UK response to the COVID-19 pandemic was the short-term prediction of hospital and critical care bed use for planning purposes. As part of this response, we developed EpiBeds, a minimally complex compartmental model tailored to data available on hospital flow and the natural history of disease progression that was available at the time. We fitted EpiBeds to four data streams: daily hospital admissions, daily hospital prevalence, daily intensive care unit (ICU) prevalence, and daily deaths in hospital, enabling us to make short-term projections of hospital and ICU bed demand, and to estimate the basic reproduction number, <italic>R</italic>. These predictions were used to support the resource management of the National Health Service of England, nationally and separately for each English region, and the other Devolved Administrations in the UK.</p>
<p>Forecasting models for hospital occupancy typically assume that individuals in certain bed types have the same waiting time distribution in that bed type regardless of outcome [<xref ref-type="bibr" rid="pcbi.1010406.ref001">1</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref002">2</xref>]. However, analysis of hospital line-list data showed that outcome was a major determinant of lengths of stay along the hospital pathway [<xref ref-type="bibr" rid="pcbi.1010406.ref003">3</xref>], and therefore in EpiBeds we defined hospital compartments not only by the current status of the patient (e.g. in critical care), but also their outcome (e.g. will recover). Defining multiple compartments was necessary since compartmental models typically require all individuals within a single compartment to have the same waiting time distribution. By doing so, we were able to maximise the information in the available data whilst minimising the complexity of the model. We reduced the number of unknown parameters using high-resolution individual-level data for a subset of hospitalised patients in England, to estimate the length of stay in each hospital compartment (conditional on the progression to each possible following stage) of the EpiBeds model.</p>
<p>Since hospitalisation data reflect background incidence, in addition to generating forecasts, EpiBeds enabled us to approximate the transmission rates in the background epidemic, and hence to provide real-time estimates of the instantaneous growth rate and effective reproduction number, published weekly by the UK Government. When policy was known to have changed recently or to be about to change, often multiple scenarios were submitted in addition to the projections (which assumed no change in transmission from the day of the projection), with a range of fixed values for the reproduction number from the date of the policy change.</p>
<p>Here we describe the motivation behind the structure of EpiBeds, including the structure of the model and the baseline parameter estimates. We then describe the model fitting procedure, outlining how the background epidemic is captured and how the model is adapted to capture changes in patient dynamics. We then illustrate the performance of the model over the first and second waves, and report posterior estimates of the key epidemiological parameters. We end with an evaluation of model performance across the first and second waves of the pandemic. The relative simplicity of EpiBeds makes it more transparent than more complex models [<xref ref-type="bibr" rid="pcbi.1010406.ref004">4</xref>–<xref ref-type="bibr" rid="pcbi.1010406.ref006">6</xref>] about:blank, and unlike other models enables us to estimate the probability of moving along different hospital pathways. The simplicity enables issues in the model fitting to be easily identified and corrected, highlighting when relationships between the underlying data streams change or the model assumptions are violated. Additionally, with the particularly sparse data at the start of the pandemic, the minimally complex design ensured minimal assumptions were required when fitting the model. The flexibility of its construction and parameterisation also means it can easily be adapted to provide accurate short-term forecasts for different countries and healthcare systems, and potentially other pathogens, with the model structure tailored to the observed data.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>2. Results</title>
<sec id="sec003">
<title>2.1. Estimates of hospital length of stay distributions</title>
<p>To inform the EpiBeds model structure, we first analysed the detailed COVID-19 Hospitalisation in England Surveillance System (CHESS) and Severe Acute Respiratory Infection (SARI) datasets (see Section SM.1.1 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary</xref> Material) to identify the most relevant hospital pathways and to estimate the distributions of the time individuals spent along each step of these hospital pathways. We classed patients using five states: <underline>H</underline>ospitalised (not been to ICU), in <underline>C</underline>ritical care (ICU), <underline>M</underline>onitored (discharged from ICU but still in hospital), <underline>R</underline>ecovered, and <underline>D</underline>eceased. After hospital admission, patients are either discharged, admitted to ICU, or die (without entering ICU), and from ICU individuals may go on to be discharged from ICU (but remain in hospital in the monitored state) or die. We then estimated the distributions of the time individuals take for each transition (hereafter referred to as “length of stay” or “delay distribution”, with the former preferred for in-hospital events and the latter preferred for out-of-hospital events), in particular: hospital admission to ICU admission, ICU admission to ICU discharge, ICU admission to death, ICU discharge to hospital discharge, hospital admission to death and hospital admission to hospital discharge. For hospital admission to death and hospital admission to discharge, we only considered patients who are not admitted to ICU, to prevent overlap with the ICU-related pathways.</p>
<p>Our aim was to produce a set of ordinary differential equations (ODEs) that best describe hospital progression. We therefore assumed length of stay distributions were gamma distributed, so that they could be approximated by Erlang distributions (see Section SM.1.2 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary</xref> Material). Since treatment policies and practices, and patient demographics, are likely to have changed over time, we estimated the waiting time distributions separately for the first (1<sup>st</sup> March 2020 to 15<sup>th</sup> September 2020) and second (1<sup>st</sup> August 2020 to 31<sup>st</sup> December 2020) waves in the UK (<xref ref-type="table" rid="pcbi.1010406.t001">Table 1</xref>), with monthly cumulative estimates given in Table D in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary</xref> Material. Our estimates are consistent with previous results for length-of-stay distributions (Fig A in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary</xref> Material), particularly findings for the UK, Europe and Japan ([<xref ref-type="bibr" rid="pcbi.1010406.ref007">7</xref>–<xref ref-type="bibr" rid="pcbi.1010406.ref016">16</xref>]). Note that the first and second wave periods have some overlap, as some historic data was needed to fit the second wave.</p>
<table-wrap id="pcbi.1010406.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.t001</object-id>
<label>Table 1</label> <caption><title>Gamma distributed length of stay for different events in hospital, estimated using the CHESS/SARI data.</title> <p>Brackets indicate 95% confidence intervals (generated through parametric bootstrapping).</p></caption>
<alternatives>
<graphic id="pcbi.1010406.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Length of stay</th>
<th align="center">Wave<xref ref-type="table-fn" rid="t001fn001"><sup>1</sup></xref></th>
<th align="center">Mean</th>
<th align="center">Standard deviation</th>
<th align="center">N</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" rowspan="2"><bold>Hosp to ICU</bold></td>
<td align="center">Wave 1</td>
<td align="center">2.79 (2.71, 2.87)</td>
<td align="center">3.30 (3.20, 3.41)</td>
<td align="center">6254</td>
</tr>
<tr>
<td align="center">Wave 2</td>
<td align="center">2.70 (2.61, 2.79)</td>
<td align="center">2.96 (2.83, 3.07)</td>
<td align="center">3830</td>
</tr>
<tr>
<td align="center" rowspan="2"><bold>ICU to death</bold></td>
<td align="center">Wave 1</td>
<td align="center">11.84 (11.43, 12.25)</td>
<td align="center">9.74 (9.35, 10.20)</td>
<td align="center">2268</td>
</tr>
<tr>
<td align="center">Wave 2</td>
<td align="center">15.33 (14.50, 16.08)</td>
<td align="center">12.38 (11.52, 13.18)</td>
<td align="center">837</td>
</tr>
<tr>
<td align="center" rowspan="2"><bold>ICU to monitoring</bold></td>
<td align="center">Wave 1</td>
<td align="center">15.93 (15.39, 16.52)</td>
<td align="center">16.97 (16.30, 17.64)</td>
<td align="center">3642</td>
</tr>
<tr>
<td align="center">Wave 2</td>
<td align="center">8.57 (8.18, 8.98)</td>
<td align="center">7.51 (7.05, 7.96)</td>
<td align="center">1348</td>
</tr>
<tr>
<td align="center" rowspan="2"><bold>Monitoring to recovery</bold></td>
<td align="center">Wave 1</td>
<td align="center">11.85 (11.39, 12.29)</td>
<td align="center">11.93 (11.37, 12.44)</td>
<td align="center">2602</td>
</tr>
<tr>
<td align="center">Wave 2</td>
<td align="center">6.45 (6.04, 6.90)</td>
<td align="center">6.58 (6.09, 7.09)</td>
<td align="center">945</td>
</tr>
<tr>
<td align="center" rowspan="2"><bold>Hosp to recovery (no ICU)</bold></td>
<td align="center">Wave 1</td>
<td align="center">9.37 (9.14, 9.60)</td>
<td align="center">9.68 (9.41, 9.96)</td>
<td align="center">6312</td>
</tr>
<tr>
<td align="center">Wave 2</td>
<td align="center">10.02 (9.66, 10.42)</td>
<td align="center">9.89 (9.43, 10.35)</td>
<td align="center">2462</td>
</tr>
<tr>
<td align="center" rowspan="2"><bold>Hosp to death (no ICU)</bold></td>
<td align="center">Wave 1</td>
<td align="center">8.93 (8.58, 9.27)</td>
<td align="center">7.81 (7.44, 8.16)</td>
<td align="center">2144</td>
</tr>
<tr>
<td align="center">Wave 2</td>
<td align="center">12.16 (11.43, 12.92)</td>
<td align="center">10.40 (9.59, 11.23)</td>
<td align="center">674</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><sup>1</sup>Wave 1 includes dates 1<sup>st</sup> March 2020 to 15<sup>th</sup> September 2020 and wave 2 dates from 1<sup>st</sup> August 2020 to 31<sup>st</sup> December.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Comparing the first wave to the second wave, we observe substantial changes in the lengths of stay on ICU. The length of stay from entering ICU to dying slightly increased between the two waves, whilst the length of stay from entering ICU to leaving ICU decreased by a factor of two. Similarly, the length of stay from leaving ICU to discharge decreased by a factor of two. There are various potential drivers for this. First, treatment changes could have reduced the length of time patients require critical care treatment, and prolonged the time until death. Second, younger patients, who were more common in the second wave, take less time to recover and longer to die. The lengths of stay without ICU does not show the same drop in the time to recovery as seen in ICU, but has a similar increase in the time to death, possibly because of improved quality of treatment.</p>
</sec>
<sec id="sec004">
<title>2.2. Construction of a compartmental model informed by hospital flow data</title>
<p>Informed by the estimated length of stay distributions (<xref ref-type="table" rid="pcbi.1010406.t001">Table 1</xref>), we constructed a compartmental model describing the progression of individuals through the hospital pathways (<xref ref-type="fig" rid="pcbi.1010406.g001">Fig 1</xref>). To account for considerable differences in the duration of different hospital transitions even from the same state, we divided individuals into compartments both in terms of their current status (e.g., Hospitalised or Critical care) and in terms of their future outcome (e.g., will recover, will die). This approach requires more parameters than the more common approach based on competing hazards but is more flexible (resulting in more general phase-type sojourn times in each state) and can be directly parameterised with the available data. Since the mean and standard deviation of the estimated lengths of stay in each compartment are similar, this indicates the gamma distributions are approximately exponential (shape parameter 1). Therefore, flows between hospital compartments are suitably described by constant transition rates (equal to the inverse of the mean of the exponentially distributed sojourn time in the compartment, see Section 4.1 [<xref ref-type="bibr" rid="pcbi.1010406.ref017">17</xref>]). The resultant hospital flow is shown by the red and orange compartments in <xref ref-type="fig" rid="pcbi.1010406.g001">Fig 1</xref>.</p>
<fig id="pcbi.1010406.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Schematic representation of the EpiBeds model.</title>
<p>The construction of the compartmental model was informed by available data. EpiBeds is implemented as a set of ordinary differential equations (ODEs), with one state variable per compartment representing the absolute number of individuals in it. Arrows describe flow between compartments, which occurs at constant rate. Blue compartments indicate infected individuals who are not hospitalised, with a dark and light blue distinction, respectively, for individuals with and without symptoms, while red compartments indicate hospitalised individuals and orange compartments individuals in critical care. The compartments with a red border contain infectious individuals, with a dashed border denoting an infectivity reduced to 25% of that of the other infectious compartments; once hospitalised, it is assumed individuals no longer contribute to the community epidemic. For states in which the waiting times are not exponentially distributed (e.g. <underline>E</underline>xposed) we use multiple identical compartments enabling us to approximate gamma-distributed waiting times by using Erlang distributions. All variables, rates, and probabilities are described in Tables <xref ref-type="table" rid="pcbi.1010406.t002">2</xref> and <xref ref-type="table" rid="pcbi.1010406.t003">3</xref>. The force of infection λ depends on the numbers in the infectious compartments (Section 4.1).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.g001" xlink:type="simple"/>
</fig>
<p>Since the infectious burden in the population determines the rate at which cases will be admitted to hospital, we also used compartments to describe the process of infection in the general population, based on an SEIR (<underline>S</underline>usceptible <underline>E</underline>xposed <underline>I</underline>nfectious <underline>R</underline>ecovered) model structure. Symptomatic individuals therefore go through three states of infection, <underline>E</underline>xposed (but not yet infectious), <underline>I</underline>nfectious (but not yet symptomatic), and <underline>L</underline>ate infection (infectious and symptomatic), with a proportion of symptomatic individuals requiring hospitalisation (L<sub>H</sub>) and the other proportion recovering naturally (L<sub>R</sub>). The latter distinction is motivated by the fact that the processes of biological recovery and hospital seeking behaviour are conceptually different, hence involving different progression rates: for an infected individual, the time to recovery reflects the natural course of a non-severe infection, while the time to hospital admission is driven by hospital seeking behaviour, current policy, and health-care logistic availability. A proportion of individuals are assumed to remain asymptomatic throughout infection; these individuals follow an infection pathway that is distinct from, but mimics, that of symptomatic individuals.</p>
<p>The structure for the generalised epidemic was constructed to reflect delay distributions from the literature, using constant rates to represent exponentially distributed sojourn times, and sequences of compartments to represent gamma-distributed sojourn times (more details in Section 4.1). This is known as “linear chain trickery” and is a way of representing gamma-distributed sojourn times by using the Erlang distribution. Hence, to describe a gamma-distributed incubation period (i.e., the time from infection to symptom onset) with mean 4.85 days and shape parameter 3 [<xref ref-type="bibr" rid="pcbi.1010406.ref018">18</xref>], we used three subsequent compartments (E<sub>1</sub>,E<sub>2</sub>, I) with identical constant rates between them, with mean sojourn time 1.6 days in each compartment [<xref ref-type="bibr" rid="pcbi.1010406.ref017">17</xref>]. This assumes pre-symptomatic transmission of 1.6 days, which is roughly consistent with literature estimates that show most pre-symptomatic transmission occurs in the two days prior to symptom onset [<xref ref-type="bibr" rid="pcbi.1010406.ref019">19</xref>]. The delay between symptom onset and hospitalisation is gamma distributed with shape parameter approximately equal to two [<xref ref-type="bibr" rid="pcbi.1010406.ref018">18</xref>], and we therefore used two compartments for late-infection symptomatic individuals who will be hospitalised (L<sub>H</sub>). For cases that recover without hospitalisation, in the absence of better data on the duration of infectivity since symptom onset, we made the parsimonious choice of a single late infection compartment with an exponentially distributed length of stay with mean 3.5 days, such that the overall period during which an individual is actively infectious (I plus the L compartments) is consistent with the 5-day mean generation time estimated in [<xref ref-type="bibr" rid="pcbi.1010406.ref020">20</xref>]. The resultant compartmental model is illustrated in <xref ref-type="fig" rid="pcbi.1010406.g001">Fig 1</xref>, with the state variables and parameters described in Tables <xref ref-type="table" rid="pcbi.1010406.t002">2</xref> and <xref ref-type="table" rid="pcbi.1010406.t003">3</xref>. The equations are reported in Section 4.1.</p>
<table-wrap id="pcbi.1010406.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.t002</object-id>
<label>Table 2</label> <caption><title>State variables for the compartmental model.</title></caption>
<alternatives>
<graphic id="pcbi.1010406.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">State variable</th>
<th align="left">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">S</td>
<td align="left">Susceptible</td>
</tr>
<tr>
<td align="left">E<sub>A</sub>, E<sub>S</sub></td>
<td align="left">Exposed–will stay asymptomatic, become symptomatic</td>
</tr>
<tr>
<td align="left">I<sub>A</sub>, I<sub>S</sub></td>
<td align="left">Infectious–will stay asymptomatic, become symptomatic</td>
</tr>
<tr>
<td align="left">A<sub>R</sub></td>
<td align="left">Asymptomatic–will recover</td>
</tr>
<tr>
<td align="left">L<sub>R</sub>, L<sub>H</sub></td>
<td align="left">Late infection (symptomatic)–will recover, be hospitalised</td>
</tr>
<tr>
<td align="left">H<sub>R</sub>, H<sub>C</sub>, H<sub>D</sub></td>
<td align="left">Hospitalised–will recover, enter critical care, die without entering critical care</td>
</tr>
<tr>
<td align="left">C<sub>M</sub>, C<sub>D</sub></td>
<td align="left">Critical care–will be monitored before recovery, die</td>
</tr>
<tr>
<td align="left">M<sub>R</sub></td>
<td align="left">Monitored–will recover</td>
</tr>
<tr>
<td align="left">R</td>
<td align="left">Recovered</td>
</tr>
<tr>
<td align="left">D</td>
<td align="left">Deceased</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="pcbi.1010406.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.t003</object-id>
<label>Table 3</label> <caption><title>Parameter variables and values for the compartmental model.</title></caption>
<alternatives>
<graphic id="pcbi.1010406.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Parameter variable</th>
<th align="left">Description</th>
<th align="left">Fixed parameter or prior distribution</th>
<th align="left">Literature range</th>
<th align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><italic>r</italic><sub><italic>E</italic></sub></td>
<td align="left">Rate of transition through early stage infectious classes (E<sub>S</sub>, I<sub>S</sub>, E<sub>A</sub>, I<sub>A</sub>)</td>
<td align="left">1/4.85</td>
<td align="left">1/4.85</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref018">18</xref>]</td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>AR</italic></sub></td>
<td align="left">Rate of transition from late stage asymptomatic (A<sub>R</sub>) to recovered (R)</td>
<td align="left">1/3.5</td>
<td align="left">(see text)</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref020">20</xref>]</td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>LR</italic></sub></td>
<td align="left">Rate of transition from late stage symptomatic (L<sub>R</sub>) to recovered (R)</td>
<td align="left">1/3.5</td>
<td align="left">(see text)</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref020">20</xref>]</td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>LH</italic></sub></td>
<td align="left">Rate of transition from late stage severely symptomatic (L<sub>H</sub>)</td>
<td align="left">1/5.2</td>
<td align="left">1/5.2</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref018">18</xref>]</td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>HR</italic></sub></td>
<td align="left">Rate of transition from hospital admission (H<sub>R</sub>) to recovered (R), without ICU</td>
<td align="left">1/9.37 –Wave 1<break/>1/10.02 –Wave 2</td>
<td align="left">1/6.1</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref021">21</xref>], Table D in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref></td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>HC</italic></sub></td>
<td align="left">Rate of transition from hospital admission (H<sub>C</sub>) to ICU (C<sub>M</sub>, C<sub>D</sub>)</td>
<td align="left">1/2.79 –Wave 1<break/>1/2.70 –Wave 2</td>
<td align="left">1/4 to 1/1.5</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref007">7</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref008">8</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref021">21</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref022">22</xref>], Table D in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref></td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>HD</italic></sub></td>
<td align="left">Rate of transition from hospital admissions (H<sub>D</sub>) to death (D), without ICU</td>
<td align="left">1/8.93 –Wave 1<break/>1/12.16 –Wave 2</td>
<td align="left">1/9.8 to 1/7.5</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref023">23</xref>], Table D <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 in</xref> Supplementary Material</td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>CM</italic></sub></td>
<td align="left">Rate of transition from critical care admission (C<sub>M</sub>) to step down (M<sub>R</sub>)</td>
<td align="left">1/15.93 –Wave 1<break/>1/8.57 –Wave 2</td>
<td align="left">1/16.8 to 1/12</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref011">11</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref021">21</xref>], Table D in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref></td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>CD</italic></sub></td>
<td align="left">Rate of transition from critical care admission (C<sub>D</sub>) to death (D)</td>
<td align="left">1/11.84 –Wave 1<break/>1/15.33 –Wave 2</td>
<td align="left">1/17 to 1/7</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref007">7</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref011">11</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref013">13</xref>], Table D in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref></td>
</tr>
<tr>
<td align="left"><italic>r</italic><sub><italic>MR</italic></sub></td>
<td align="left">Rate of transition from step down (M<sub>R</sub>) to discharge (R)</td>
<td align="left">1/11.85 –Wave 1<break/>1/6.45 –Wave 2</td>
<td align="left">1/7</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref011">11</xref>], Table D <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 in</xref> Supplementary Material</td>
</tr>
<tr>
<td align="left"><italic>p</italic><sub><italic>A</italic></sub></td>
<td align="left">Proportion of infected individuals that will be asymptomatic</td>
<td align="left">0.55</td>
<td align="left">0.179 to 0.972</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref024">24</xref>–<xref ref-type="bibr" rid="pcbi.1010406.ref028">28</xref>]</td>
</tr>
<tr>
<td align="left"><italic>p</italic><sub><italic>H</italic></sub></td>
<td align="left">Proportion of symptomatic individuals that will be hospitalised</td>
<td align="left">0.08</td>
<td align="left">0.036 to 0.155</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref021">21</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref022">22</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref029">29</xref>]</td>
</tr>
<tr>
<td align="left"><italic>p</italic><sub><italic>C</italic></sub></td>
<td align="left">Proportion of hospitalised individuals that will enter critical care</td>
<td align="left">Uninformative<break/>prior</td>
<td align="left">0.091 to 0.485</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref008">8</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref014">14</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref021">21</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref022">22</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref029">29</xref>]</td>
</tr>
<tr>
<td align="left"><italic>p</italic><sub><italic>T</italic></sub></td>
<td align="left">Proportion of hospitalised individuals that will die without entering critical care</td>
<td align="left">Uninformative<break/>prior</td>
<td align="left">0.316</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref008">8</xref>]</td>
</tr>
<tr>
<td align="left"><italic>p</italic><sub><italic>D</italic></sub></td>
<td align="left">Proportion of individuals in critical care that will die</td>
<td align="left"><xref ref-type="table-fn" rid="t003fn001"><sup>1</sup></xref>Wave 1: 0.357 (0.319–0.384)<break/>Wave 2: 0.287 (0.265–0.321)</td>
<td align="left">0.4 to 0.453</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1010406.ref008">8</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref011">11</xref>]</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p><sup>1</sup>We used a strongly informative Normal prior distribution obtained from SARI data, with mean and 95% CI shown.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>We assumed only non-hospitalised infectious individuals contribute to new infections, with asymptomatic individuals less infectious than individuals who are pre-symptomatic or symptomatic. Due to behavioural changes, changes in test specificity, and the possibility that asymptomatic cases may correspond to individuals who simply have a long incubation period, identification of the relative infectivity of an asymptomatic case is challenging. We assume relative infectivity of 25%, based on [<xref ref-type="bibr" rid="pcbi.1010406.ref030">30</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref031">31</xref>]. We assume that asymptomatic cases make up 55% of infections, which we determined by adjusting age specific estimates of the asymptomatic rate to the age distribution in England [<xref ref-type="bibr" rid="pcbi.1010406.ref024">24</xref>]. Although infections from hospitalised patients could have an effect on the overall epidemic, most notably with health care workers as transmission links, detailed genetic data are required to characterise this process [<xref ref-type="bibr" rid="pcbi.1010406.ref032">32</xref>]. We also assume that nosocomial cases do not substantially alter hospital flow, i.e., upon testing positive nosocomial patients follow similar pathways to community-acquired cases. In the hospital admissions data, we either count patients from admission (if they were tested in the community) or from the date of their first positive swab result (if they were tested in hospital). This second cohort will include all nosocomial cases, who we treat as being admitted from the community.</p>
</sec>
<sec id="sec005">
<title>2.3. Model fitting</title>
<sec id="sec006">
<title>2.3.1. Procedure</title>
<p>We fitted EpiBeds to English data (SITREP—NHS situation report and CPNS—COVID-19 Patient Notification System) using a Bayesian MCMC approach (Section 4.2). When fitting to data, we considered waves one and two independently in order to capture temporal changes in the hospital dynamics. Since there were substantial parameter changes between the first and second wave, when fitting the second wave we used admissions for the whole time-series combined with beds, ICU, and deaths data only from 1<sup>st</sup> August 2020 onwards. This enabled the probabilities to be fitted to the second wave independently of the first wave, while still accounting for the depletion of susceptibles throughout the first wave and reasonable initial conditions for all variables at the start of the second wave.</p>
<p>To reduce the number of free parameters, we used the average waiting times in each hospital compartment for each wave estimated from the CHESS/SARI data (<xref ref-type="table" rid="pcbi.1010406.t001">Table 1</xref>), and previously published estimates for disease parameters (<xref ref-type="table" rid="pcbi.1010406.t003">Table 3</xref>), as fixed model parameters. For the remaining parameters (<xref ref-type="table" rid="pcbi.1010406.t003">Table 3</xref>) we used uninformative priors with the exception of the probabilities of death if in ICU (<italic>p</italic><sub><italic>D</italic></sub>). This is because the data on deaths and recoveries do not distinguish whether individuals have transitioned to ICU or not, and hence are both affected simultaneously by a combination of <italic>p</italic><sub><italic>C</italic></sub> and <italic>p</italic><sub><italic>D</italic></sub> (through ICU) and <italic>p</italic><sub><italic>T</italic></sub> (without passing through ICU) thus making these three parameters only weakly identifiable (at best) if at least one of them is not constrained separately. For <italic>p</italic><sub><italic>D</italic></sub> we used a strongly informative Normal prior distribution with a mean and 95% CI estimated from CHESS/SARI data for wave one at 35.7% (31.9%, 38.4%) and for wave 2 at 28.7% (26.5%, 32.1%). Obtaining similar priors for <italic>p</italic><sub><italic>T</italic></sub> and <italic>p</italic><sub><italic>C</italic></sub> (probability of entering ICU if hospitalised) was not possible due to insufficient and geographically uneven coverage in the data, causing problems in both power and representativeness.</p>
<p>The background epidemic is driven by a transmission rate, that represents the total infectious pressure exerted by a symptomatic infectious individual. This parameter collates contact behaviour, transmission probability of contacts and strength of contacts into a single parameter. On an individual level, this does not provide accurate information about the transmission dynamics, but on a population level aggregating all of these into a single parameter is a simple way to represent the average transmission dynamics in the population.</p>
<p>To model the background epidemic, we need to estimate the value of this transmission parameter. We cannot assume this transmission rate is constant, because there are large changes in this parameter across the pandemic, for example due to behavioural changes, implementation of control policies, and circulation of different variants. However, we do not want to add too many different values, as this risks overfitting noise in the data rather than genuine changes in transmission. To capture these large changes, we assumed the transmission rate was piecewise constant with pre-selected change points that generally correspond to large policy changes:</p>
<list list-type="bullet">
<list-item><p>13<sup>th</sup> March 2020 (visible change in hospitalisation trend, possibly due to media-driven behavioural changes or inaccuracies in recording early hospitalisation data),</p></list-item>
<list-item><p>24<sup>th</sup> March 2020 (beginning of a UK-wide lockdown),</p></list-item>
<list-item><p>11<sup>th</sup> April 2020 (visible change in trend towards the end of lockdown),</p></list-item>
<list-item><p>15<sup>th</sup> August 2020 (visible rise in hospital admissions),</p></list-item>
<list-item><p>6<sup>th</sup> September 2020 (visible change in trend),</p></list-item>
<list-item><p>14<sup>th</sup> October 2020 (Merseyside first area in England to enter “tier 3” restrictions),</p></list-item>
<list-item><p>5<sup>th</sup> November 2020 (England-wide second lockdown),</p></list-item>
<list-item><p>18<sup>th</sup> November 2020 (indicated by an increase in infections due to the rise of the B.1.1.7 variant–now called Alpha–in England and potentially increasing social interactions, this also encompasses any transmission changes after lifting the second lockdown on 2 December 2020).</p></list-item>
</list>
<p>In addition, we included change points three weeks before the final data point, unless a major intervention was already present within the last three weeks. This translates in additional transmission rate changes on:</p>
<list list-type="bullet">
<list-item><p>25<sup>th</sup> August 2020, when producing the fit to the entire first wave (<xref ref-type="fig" rid="pcbi.1010406.g002">Fig 2</xref>),</p></list-item>
<list-item><p>10<sup>th</sup> December 2020, when producing the fit to the entire second wave (<xref ref-type="fig" rid="pcbi.1010406.g003">Fig 3</xref>).</p></list-item>
</list>
<p>We refer to the periods during which transmission rates are assumed to be constant as constant-transmission intervals. Although further changes in transmission rates could have been added, this risked overfitting to noise in the data rather than genuine transmission trends. For a full description see Supplementary Methods in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>.</p>
<fig id="pcbi.1010406.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.g002</object-id>
<label>Fig 2</label>
<caption>
<title/>
<p>First-wave model fit to admissions (red), beds (blue), ICU beds (cyan) and deaths (magenta). Vertical lines indicate when transmission rate changes are added to EpiBeds (see Section SM.1.3.3 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>). Note that there is a delay between transmission changing in the community and its effect being observed in the hospital data, so visual inflections in the model trend occur after the transmission change point. The 90% prediction interval was calculated by generating, for each parameter posterior sample, a new potential realisation of the data and then taking the 5 and 95 quantiles of the set of realised data at each time point. All dates are given as day/month/year.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.g002" xlink:type="simple"/>
</fig>
<fig id="pcbi.1010406.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.g003</object-id>
<label>Fig 3</label>
<caption>
<title/>
<p>Second-wave model fit to admissions (red), beds (blue), ICU beds (cyan) and deaths (magenta). Admissions data were fitted starting from 1<sup>st</sup> March 2020, while the other three data streams were fitted starting from 1<sup>st</sup> August 2020. Vertical lines indicate when transmission rate changes are added to EpiBeds (see Section SM.1.3.3 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>). Note that there is a delay between transmission changing in the community and its effect being observed in the hospital data, so visual inflections in the model trend occur after the transmission change point. The 90% prediction interval was calculated by generating, for each parameter posterior sample, a new potential realisation of the data and then taking the 5 and 95 quantiles of the set of realised data at each time point. All dates are given as day/month/year.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec007">
<title>2.3.2. EpiBeds captures the dynamics of the first and second waves in England</title>
<p>EpiBeds performed well in capturing the dynamics of both the first and second waves (Figs <xref ref-type="fig" rid="pcbi.1010406.g002">2</xref> and <xref ref-type="fig" rid="pcbi.1010406.g003">3</xref>). For the first wave, the model fits admissions and hospital beds particularly well (low overdispersion of data around the average model prediction), whereas ICU occupancy and deaths required high overdispersion to capture the data. This is driven by multiple factors including: data quality issues between data streams at the start of the first wave; a large shift in the age distribution of admissions from frailer older people in the spring to younger people with low mortality risk in the summer; and changes in treatment which likely altered outcome probabilities.</p>
<p>For the second wave (<xref ref-type="fig" rid="pcbi.1010406.g003">Fig 3</xref>), there is better agreement among the data streams, due to more consistent reporting of data by the hospital trusts, less demographic shift in hospital admissions, and less dramatic changes in treatments, compared to the first wave. Although EpiBeds links all four data streams well during this period, there was a sharper increase in ICU admission during September 2020 than the model captured. During this period, admissions were concentrated in the relatively young, with severely ill younger patients more likely to visit ICU rather than be treated on the ward compared to older patients, since younger patients have more favourable ICU outcomes. As the epidemic spread through the community, the age distribution became relatively stable, corresponding to a slowdown in the ICU admission rate from October. Due to data quality issues in the early admissions data, we changed the data definitions used between the first and second waves slightly (see Section SM.1.1 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>), resulting in higher admissions in the data used when fitting the second wave. Since for the second wave we only fitted the other three streams from 1<sup>st</sup> August 2020 onwards, these data quality issues no longer affect the performance of EpiBeds when linking the four data streams.</p>
</sec>
<sec id="sec008">
<title>2.3.3. The probabilities of dying, with and without ICU, declined significantly between waves</title>
<p>Through the model fitting we obtained posterior estimates for the free parameters (see Table SM.1.2 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref> for the list of parameters—estimates are only reported for those with epidemiological significance, posterior distributions for all parameters can be found on Github [<xref ref-type="bibr" rid="pcbi.1010406.ref033">33</xref>]), including the outcome probabilities <italic>p</italic><sub><italic>D</italic></sub>, <italic>p</italic><sub><italic>T</italic>,</sub> and <italic>p</italic><sub><italic>C</italic></sub> (<xref ref-type="table" rid="pcbi.1010406.t004">Table 4</xref>). These outcome probabilities were assumed to be constant throughout each wave and are presented only at the end of wave one (15<sup>th</sup> September 2020) and wave two (31<sup>st</sup> December 2020), to highlight the difference between waves (<xref ref-type="table" rid="pcbi.1010406.t004">Table 4</xref>). Since we used strongly informative priors for <italic>p</italic><sub><italic>D</italic></sub>, the posterior estimates of <italic>p</italic><sub><italic>D</italic></sub> generated through MCMC remained close to the prior, though we did observe a significant reduction between waves one and two (from 34% to 30%). The estimated probability of being admitted to ICU (<italic>p</italic><sub><italic>C</italic></sub>) remained relatively constant throughout 2020 at ~13%, in line with previous estimates [<xref ref-type="bibr" rid="pcbi.1010406.ref003">3</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref019">19</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref021">21</xref>]. In contrast, the probability of dying without entering ICU (<italic>p</italic><sub><italic>T</italic></sub>) dropped by more than 25% between the two waves, from 32% to 23%. These posterior estimates are consistent with the range of estimates from the literature (Fig C in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>).</p>
<table-wrap id="pcbi.1010406.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.t004</object-id>
<label>Table 4</label> <caption><title>Posterior estimates for hospital pathway proportions during 2020.</title> <p>Note that these periods overlap because some historic data were needed to fit the second wave.</p></caption>
<alternatives>
<graphic id="pcbi.1010406.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Parameter</th>
<th align="left">Before 15<sup>th</sup> September</th>
<th align="left">After 1<sup>st</sup> August</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Proportion of hospitalised individuals that will enter critical care, <italic>p</italic><sub><italic>C</italic></sub></td>
<td align="left">0.125 (0.119, 0.130)<xref ref-type="table-fn" rid="t004fn001"><sup>1</sup></xref></td>
<td align="left">0.127 (0.123, 0.129)</td>
</tr>
<tr>
<td align="left">Proportion of hospitalised individuals that will die without entering critical care, <italic>p</italic><sub><italic>T</italic></sub></td>
<td align="left">0.317 (0.305, 0.329)</td>
<td align="left">0.234 (0.229, 0.240)</td>
</tr>
<tr>
<td align="left">Proportion of individuals in critical care that will die, <italic>p</italic><sub><italic>D</italic></sub></td>
<td align="left">0.344 (0.318, 0.372)</td>
<td align="left">0.296 (0.270, 0.321)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p><sup>1</sup>Parentheses indicate 90% credible intervals</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In line with other published estimates [<xref ref-type="bibr" rid="pcbi.1010406.ref003">3</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref022">22</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref029">29</xref>], we estimated 13% of COVID-19 patients were admitted to ICU, during both the first and second waves in England. The proportion of patients surviving on ICU improved over time, with 34% mortality during the first wave and 30% during the second wave. An even stronger reduction in mortality occurred outside the ICU, with 32% of admissions dying without ICU during the first wave and 23% during the second wave. This reflects the change in the age distribution of cases and potential improvements in treatments. Given only 13% of admitted patients went to ICU, the vast majority of deaths occurred outside of ICU (about 89% and 84% of deaths during the two waves). In most cases these were frail individuals for whom ICU was unsuitable.</p>
</sec>
<sec id="sec009">
<title>2.3.4. Reproduction numbers fluctuated considerably during 2020</title>
<p>Using the transmission rates determined from EpiBeds, we estimated two types of reproduction numbers: the control reproduction number <italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic> and the effective reproduction number <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> [<xref ref-type="bibr" rid="pcbi.1010406.ref006">6</xref>]. The control reproduction number <italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic> is the average number of new infections generated by an average infection started at time <italic>t</italic>, in the absence of population immunity, assuming the transmission rate does not change (e.g. due to policy changes affecting physical distancing) from its value at time <italic>t</italic>. The basic reproduction number <italic>R</italic><sub>0</sub> is then given by <italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic> before the first intervention reduces transmission by limiting the “natural” (i.e. pre-pandemic) population contact patterns. The effective reproduction number, <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> (also denoted <italic>R</italic><sub><italic>t</italic></sub>), describes the average number of new infections generated by an average infection started at time <italic>t</italic>, taking into account population immunity. This can be obtained by multiplying <italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic> by the susceptible fraction of the population at time <italic>t</italic>.</p>
<p>We calculated <italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic> and <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> (Section 4.1) for each constant-transmission interval, using estimates of the transmission rate obtained when fitting only to data obtained during the first wave, or data from both waves (<xref ref-type="table" rid="pcbi.1010406.t005">Table 5</xref>). The longer the interval during which the transmission rate is assumed to be constant, the smaller the uncertainty. Moreover, the estimates of <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> that are obtained when only fitting the first wave are constrained by all four data streams, whilst the first wave <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> estimates obtained when fitting to the second wave are only constrained by the hospital admissions, resulting in the slightly different estimates.</p>
<table-wrap id="pcbi.1010406.t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.t005</object-id>
<label>Table 5</label> <caption><title>Posterior estimates for effective, R<sub>e</sub>(t), and control, R<sub>c</sub>(t) reproduction numbers during 2020.</title> <p>Wave-one transmission rate estimates use data captured during the first wave only, whereas wave-two uses rates were estimated using data captured from the whole epidemic (see main text for further details). The final interval ended on 31<sup>st</sup> December 2020.</p></caption>
<alternatives>
<graphic id="pcbi.1010406.t005g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.t005" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Date of change</th>
<th align="left"><italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic><xref ref-type="table-fn" rid="t005fn001"><sup>1</sup></xref> Wave 1</th>
<th align="left"><italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic><xref ref-type="table-fn" rid="t005fn002"><sup><italic>2</italic></sup></xref> Wave 1</th>
<th align="left"><italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic><xref ref-type="table-fn" rid="t005fn001"><sup>1</sup></xref> Wave 2</th>
<th align="left"><italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic><xref ref-type="table-fn" rid="t005fn002"><sup>2</sup></xref> Wave 2</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>31</bold><sup><bold>st</bold></sup> <bold>January 2020</bold></td>
<td align="left">5.87 (5.32, 6.54)^</td>
<td align="left">5.87 (5.32, 6.54)^</td>
<td align="left">5.44 (4.51, 6.35)<xref ref-type="table-fn" rid="t005fn004">*</xref><xref ref-type="table-fn" rid="t005fn003">^</xref></td>
<td align="left">5.44 (4.51, 6.35)<xref ref-type="table-fn" rid="t005fn004">*</xref><xref ref-type="table-fn" rid="t005fn003">^</xref></td>
</tr>
<tr>
<td align="left"><bold>13</bold><sup><bold>th</bold></sup> <bold>March 2020</bold></td>
<td align="left">3.02 (2.91, 3.12)</td>
<td align="left">3.02 (2.91, 3.12)</td>
<td align="left">2.84 (2.64, 3.02)<xref ref-type="table-fn" rid="t005fn004">*</xref></td>
<td align="left">2.84 (2.64, 3.02)<xref ref-type="table-fn" rid="t005fn004">*</xref></td>
</tr>
<tr>
<td align="left"><bold>24</bold><sup><bold>th</bold></sup> <bold>March 2020</bold></td>
<td align="left">0.67 (0.65, 0.68)</td>
<td align="left">0.67 (0.65, 0.68)</td>
<td align="left">0.78 (0.76, 0.81)<xref ref-type="table-fn" rid="t005fn004">*</xref></td>
<td align="left">0.78 (0.76, 0.81)<xref ref-type="table-fn" rid="t005fn004">*</xref></td>
</tr>
<tr>
<td align="left"><bold>11</bold><sup><bold>th</bold></sup> <bold>April 2020</bold></td>
<td align="left">0.81 (0.80, 0.81)</td>
<td align="left">0.81 (0.80, 0.81)</td>
<td align="left">0.80 (0.79, 0.80)<xref ref-type="table-fn" rid="t005fn004">*</xref></td>
<td align="left">0.80 (0.79, 0.80)<xref ref-type="table-fn" rid="t005fn004">*</xref></td>
</tr>
<tr>
<td align="left"><bold>10</bold><sup><bold>th</bold></sup> <bold>August 2020</bold></td>
<td align="left">1.02 (0.88, 1.17)</td>
<td align="left">1.18 (1.02, 1.36)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr>
<td align="left"><bold>15</bold><sup><bold>th</bold></sup> <bold>August 2020</bold></td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1.62 (1.60, 1.65)</td>
<td align="left">1.71 (1.68, 1.74)</td>
</tr>
<tr>
<td align="left"><bold>6</bold><sup><bold>th</bold></sup> <bold>September 2020</bold></td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1.48 (1.47, 1.49)</td>
<td align="left">1.57 (1.55, 1.68)</td>
</tr>
<tr>
<td align="left"><bold>14</bold><sup><bold>th</bold></sup> <bold>October 2020</bold></td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1.23 (1.22, 1.24)</td>
<td align="left">1.30 (1.29, 1.31)</td>
</tr>
<tr>
<td align="left"><bold>5</bold><sup><bold>th</bold></sup> <bold>November 2020</bold></td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">0.80 (0.78, 0.83)</td>
<td align="left">0.85 (0.83, 0.88)</td>
</tr>
<tr>
<td align="left"><bold>18</bold><sup><bold>th</bold></sup> <bold>November 2020</bold></td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1.15 (1.13, 1.17)</td>
<td align="left">1.23 (1.21, 1.25)</td>
</tr>
<tr>
<td align="left"><bold>10</bold><sup><bold>th</bold></sup> <bold>December 2020</bold></td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1.43 (1.39, 1.46)</td>
<td align="left">1.54 (1.50, 1.57)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t005fn001"><p><sup>1</sup>R<sub>e</sub>(t) estimates are given for the new transmission after a date of change. Early R<sub>e</sub>(t) estimates do not substantially differ from R<sub>c</sub>(t) estimates due in negligible susceptible depletion.</p></fn>
<fn id="t005fn002"><p><sup>2</sup>R<sub>c</sub>(t) estimates are given for the interval beginning at the date of change until the next date of change.</p></fn>
<fn id="t005fn003"><p>^ Based on very few data points, since the data starts on 1<sup>st</sup> March 2020, so may be unreliable. See trace plots (Fig A in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>) for poor identifiability of the initial growth rate.</p></fn>
<fn id="t005fn004"><p>*Based only on admissions rather than all four data streams so may be less reliable.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Although <italic>R</italic><sub><italic>c</italic></sub><italic>(t)</italic> is proportional to the transmission rate and hence is constant throughout each constant-transmission interval, as the proportion of susceptibles changes continuously over time, so does <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic>, and therefore, we report the value of <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> only at the start of each constant-transmission interval. The first lockdown significantly reduced the transmission rate. As lockdown went on, <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> increased slightly, as indicated by the transmission rate change on 11<sup>th</sup> April 2020. Over August, transmission increased, bringing <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> above 1. This growth continued until further interventions were brought in with the local tier system. This reduced the transmission rate, likely driven by the effectiveness of the tier 3 interventions in the North West. Finally, the second lockdown brought transmission down across the whole of England, bringing again <italic>R</italic><sub><italic>e</italic></sub><italic>(t)</italic> below 1. Note that, using this model the initial reproduction number is not reliably constrained, since there are very few data points informing the initial transmission rate. This lack of identifiability is reflected in the MCMC trace plots (Fig A in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>).</p>
</sec>
</sec>
<sec id="sec010">
<title>2.4. Short-term forecasts were accurate unless transmission rates changed markedly during the forecasting window</title>
<p>To evaluate the performance of EpiBeds as a tool for real-time monitoring of the evolving epidemic in England, we performed two-week projections made on days 1 and 15 of each month, from March to December 2020, based on the data available at that time. We illustrate these projections in <xref ref-type="fig" rid="pcbi.1010406.g004">Fig 4</xref>, superimposed to the complete data for both waves. The posterior parameter estimates vary at every projection due to the additional data at each successive time point. We do not report the specific parameter estimates from each model fitting, but only the projections for the data streams. See Section SM.1.3.4 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref> for details on the setup when generating these results.</p>
<fig id="pcbi.1010406.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1010406.g004</object-id>
<label>Fig 4</label>
<caption>
<title>England hospital forecasts.</title>
<p>Green shaded regions are the 90% prediction intervals from forecasts up to 15<sup>th</sup> September 2020. Blue shaded regions are the 90% prediction intervals from forecasts after 1<sup>st</sup> October 2020 (using data from 1<sup>st</sup> August 2020). Vertical black lines mark where major transmission changes occur, with changes in trajectory only manifesting after a delay that is data stream dependent. The y-axis is truncated to aid visibility, though a few forecast regions do exceed the y-limit.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.g004" xlink:type="simple"/>
</fig>
<p>For the first forecasts (start date 1<sup>st</sup> April 2020), a transmission change was added on 24<sup>th</sup> March 2020 to allow EpiBeds to adjust transmission based on lockdown. Such a short fitting window resulted in large uncertainty, with both growing and declining epidemics falling within the 90% prediction interval. By the 15<sup>th</sup> April 2020 forecast, a peak had been observed in the admissions data, but EpiBeds was unable to reconcile the four data streams, which resulted in the forecasts underestimating the reduction in the transmission rate and overshooting the data. This poor performance could be driven by multiple factors, such as challenges with estimating length of stay early in the pandemic (Sections SM.1.2 and SM.3 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>), changing demographics after entering the first lockdown, and data quality issues in some of the data streams (Section SM.1.1 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>). After this point, forecasts remained reliable into the summer.</p>
<p>As transmission started to rise again, EpiBeds was able to accurately forecast the rise in all four data streams. However, throughout September and October, there was a demographic change, from younger to older age groups. This led to the ICU probability gradually declining and the mortality rate increasing, and the forecasts overestimated and underestimated, respectively, these two data streams. In November, the demographic distribution of cases stabilised, and EpiBeds was able to reconcile all four data streams. Noticeably, the 1<sup>st</sup> December 2020 forecast completely missed the trend in the data. This was partly to be expected since 2<sup>nd</sup> December 2020 marked the end of the second England-wide lockdown, and prior to this transmission rates were also likely to have been increasing due to behaviour changes and the emergence of the more transmissible Alpha variant [<xref ref-type="bibr" rid="pcbi.1010406.ref034">34</xref>].</p>
<p>Overall, 77% of data points, across all 4 data streams, fell within the 90% prediction intervals admissions 76%; hospital beds 80%; ICU beds 73%; deaths 80%). In many cases when data points fall out of the 90% prediction interval occur where an intervention was introduced during the forecasting window. Others potentially arise from data quality issues between the data streams, particularly during the first wave. Overall, this shows reasonably good model performance, and in practice throughout the pandemic EpiBeds has provided reliable forecasts in all regions where it was used. Our results highlight the context dependence of model performance, with lower predictive ability when transmission rates change frequently, and conversely greatly predictive ability when transmission rates are relatively stable.</p>
</sec>
</sec>
<sec id="sec011" sec-type="conclusions">
<title>3. Discussion</title>
<p>To make short-term predictions for the flow of patients through hospitals we developed EpiBeds, a compartmental model tailored to available line list data. The explicit inclusion of compartments depending on patient outcomes enabled the optimal use of available data whilst keeping model complexity low. By fitting the model to hospital occupancy data, we estimated the proportion of patients entering each hospital pathway, generated short-term hospital occupancy predictions, and helped inform management of hospital caseloads. Using the model, we were also able to estimate the effective and control reproduction numbers during different periods of the epidemic, corresponding to substantial changes in the hospital trends driven by major policy changes, the emergence of new variants, and seasonal effects. As well determining changes in the reproduction number during the 2020 epidemic in England, which largely corresponded to changes in policy, we also captured the greater proportion of hospitalised patients recovering between the first and second waves.</p>
<p>We validated the short-term forecasting performance of EpiBeds by generating 14-day forecasts using data available at the start and midpoint of each month. Due to the potentially fast-growing nature of COVID-19 outbreaks [<xref ref-type="bibr" rid="pcbi.1010406.ref018">18</xref>] about:blank, and the limited duration of most interventions, long-term forecasting is limited, since conditions are likely to have changed between the production of the forecast and reaching the forecast horizon. Because of the delay of a few weeks between the implementation of interventions and their effects on hospital admissions [<xref ref-type="bibr" rid="pcbi.1010406.ref018">18</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref035">35</xref>], short-term forecasts of a few weeks should not be significantly affected, and are valuable planning tools for hospitals and health services. Most of our forecasts captured the data within the 90% prediction interval of the forecasts, demonstrating the reliability of EpiBeds for providing short-term hospital flow predictions. When transmission rates were stable, forecasting accuracy was particularly high. However, large changes in transmission rates, for example due to major policy changes and the emergence the Alpha variant, reduced the forecasting accuracy. Data quality issues can also affect predictions, and this likely contributed to some of the forecasting inaccuracies we observed during the first wave.</p>
<p>EpiBeds was developed specifically to provide predictions of hospital occupancy and designed to maximise the information in available data whilst minimising the inclusion of unsupported assumptions. For this reason, the model is not structured by sex or age, or other comorbidities such as heart failure or chronic kidney disease, even though these are known to affect disease severity [<xref ref-type="bibr" rid="pcbi.1010406.ref012">12</xref>,<xref ref-type="bibr" rid="pcbi.1010406.ref036">36</xref>]. The SITREP does not include sex as a category and does not include age for all data streams (particularly when the model was first developed). As epidemics progress, the communities in which the virus circulates may change, which in turn could affect how individuals progress through hospital pathways, such as the probability of entering ICU if critically ill. This emphasises the need for the consistent reporting of high-quality data so that estimates can be continuously updated, resulting in more accurate forecasts. To account for demographic changes, as well as potential improvements in treatments, we fitted the parameters for the second wave independently of the first wave.</p>
<p>The structure of EpiBeds makes use of the fact that the delay distributions were approximately Erlang distributed, so that they can easily be approximated by a series of ODEs. It would be possible to instead write the model in terms of delay equations, but the ODE approach leads to significantly reduced computational cost, which is essential for a modelling product that may need to be run multiple times per week.</p>
<p>A limitation of the current framework is the assumption of complete immunity. For the time period considered, this is unlikely to have affected the results. However, with mass vaccination, immune waning and immune escape variants, more complexity may be required to capture long term dynamics. To address this, vaccinated compartments, variants, and immune waning could be added to the model. However, over the short time scales of projections considered, population immunity is unlikely to have a major influence on the dynamics, which are mostly driven by recent trends in the data.</p>
<p>Our model differs from more conventional compartmental models by defining compartments based not only on current status, but on future outcome, making it more closely aligned to the data. This alignment to data, and its relative simplicity, means EpiBeds can be used to make short-term predictions in different settings, as well as used as a framework to develop short-term forecasts in the case of new outbreaks. Moreover, the minimal complexity of EpiBeds makes it easy to identify the cause of model fitting issues, including lack of identifiability of the patient outcome probabilities without strongly informative priors and temporal changes in the relationships between the different data streams, and makes both model behaviour and model limitations transparent. We deem these to be key reasons to advocate for the use of simple models. Here, we fitted EpiBeds to hospital data for England, but it can readily be applied to other geographies. For example, as part of the COVID-19 response, we used it to generate forecasts for Scotland, Wales, Northern Ireland, and the United Kingdom, as well as for smaller English regions.</p>
</sec>
<sec id="sec012" sec-type="materials|methods">
<title>4. Methods</title>
<sec id="sec013">
<title>M.1 The ODE compartmental model for hospital flow</title>
<p>The structure of the ODE model was informed by the delay distributions (Section 2.1 and Section SM.1.2 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>). In an ODE compartmental model with constant progression rates, the permanence waiting times in each compartment are exponentially distributed with mean equal to the inverse of the rate. Since all the hospital length of stay distributions were approximately exponential (because the mean is similar to the standard deviation), we modelled the hospital compartments using constant rates. For the background epidemic, we represented the Gamma-distributed incubation period (shape parameter 3, [<xref ref-type="bibr" rid="pcbi.1010406.ref004">4</xref>]) and the Gamma-distributed time between symptom onset to hospitalisation (shape parameter 2, [<xref ref-type="bibr" rid="pcbi.1010406.ref005">5</xref>]), by using three and two compartments in sequence. This is a way of representing Gamma-distributed permanence times by using the Erlang distribution. Specifically, an Erlang distribution with shape parameter <italic>n</italic> corresponds to the sum of <italic>n</italic> independent and identically distributed exponential distributions [<xref ref-type="bibr" rid="pcbi.1010406.ref006">6</xref>]. If all rates are equal to <italic>r</italic>, the mean permanence time in a sequence of <italic>n</italic> compartments will be Erlang distributed with mean <italic>n/r</italic> and shape parameter <italic>n</italic> [<xref ref-type="bibr" rid="pcbi.1010406.ref007">7</xref>]. This results in EpiBeds described by the flowchart in <xref ref-type="fig" rid="pcbi.1010406.g001">Fig 1</xref> and by the following system of ODE’s (where the time index in all parameters and variables has been dropped for brevity)
<disp-formula id="pcbi.1010406.e001">
<alternatives>
<graphic id="pcbi.1010406.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>λ</mml:mi>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e002">
<alternatives>
<graphic id="pcbi.1010406.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e002" xlink:type="simple"/>
<mml:math display="block" id="M2">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mi>λ</mml:mi><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e003">
<alternatives>
<graphic id="pcbi.1010406.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e003" xlink:type="simple"/>
<mml:math display="block" id="M3">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e004">
<alternatives>
<graphic id="pcbi.1010406.e004g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e004" xlink:type="simple"/>
<mml:math display="block" id="M4">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mi>λ</mml:mi><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e005">
<alternatives>
<graphic id="pcbi.1010406.e005g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e005" xlink:type="simple"/>
<mml:math display="block" id="M5">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e006">
<alternatives>
<graphic id="pcbi.1010406.e006g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e006" xlink:type="simple"/>
<mml:math display="block" id="M6">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e007">
<alternatives>
<graphic id="pcbi.1010406.e007g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e007" xlink:type="simple"/>
<mml:math display="block" id="M7">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e008">
<alternatives>
<graphic id="pcbi.1010406.e008g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e008" xlink:type="simple"/>
<mml:math display="block" id="M8">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e009">
<alternatives>
<graphic id="pcbi.1010406.e009g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e009" xlink:type="simple"/>
<mml:math display="block" id="M9">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e010">
<alternatives>
<graphic id="pcbi.1010406.e010g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e010" xlink:type="simple"/>
<mml:math display="block" id="M10">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e011">
<alternatives>
<graphic id="pcbi.1010406.e011g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e011" xlink:type="simple"/>
<mml:math display="block" id="M11">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e012">
<alternatives>
<graphic id="pcbi.1010406.e012g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e012" xlink:type="simple"/>
<mml:math display="block" id="M12">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e013">
<alternatives>
<graphic id="pcbi.1010406.e013g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e013" xlink:type="simple"/>
<mml:math display="block" id="M13">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e014">
<alternatives>
<graphic id="pcbi.1010406.e014g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e014" xlink:type="simple"/>
<mml:math display="block" id="M14">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e015">
<alternatives>
<graphic id="pcbi.1010406.e015g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e015" xlink:type="simple"/>
<mml:math display="block" id="M15">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e016">
<alternatives>
<graphic id="pcbi.1010406.e016g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e016" xlink:type="simple"/>
<mml:math display="block" id="M16">
<mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
where
<disp-formula id="pcbi.1010406.e017">
<alternatives>
<graphic id="pcbi.1010406.e017g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e017" xlink:type="simple"/>
<mml:math display="block" id="M17">
<mml:mi>λ</mml:mi><mml:mo>=</mml:mo><mml:mi>S</mml:mi><mml:mi>β</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>.</mml:mo>
</mml:math>
</alternatives>
</disp-formula></p>
<p>Here, <italic>f</italic> is the reduction in transmission for asymptomatic cases, which is taken to be <italic>f = 0</italic>.<italic>25</italic>.</p>
<p>From the solution to the ordinary differential equations, the control and effective reproduction numbers can be calculated. The control reproduction number is given by
<disp-formula id="pcbi.1010406.e018">
<alternatives>
<graphic id="pcbi.1010406.e018g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e018" xlink:type="simple"/>
<mml:math display="block" id="M18">
<mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo>
</mml:math>
</alternatives>
</disp-formula>
where
<disp-formula id="pcbi.1010406.e019">
<alternatives>
<graphic id="pcbi.1010406.e019g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e019" xlink:type="simple"/>
<mml:math display="block" id="M19">
<mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo>
</mml:math>
</alternatives>
</disp-formula></p>
<p>From the control reproduction number, the effective reproduction number can be calculated as
<disp-formula id="pcbi.1010406.e020">
<alternatives>
<graphic id="pcbi.1010406.e020g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e020" xlink:type="simple"/>
<mml:math display="block" id="M20">
<mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mfrac><mml:mo>.</mml:mo>
</mml:math>
</alternatives>
</disp-formula></p>
</sec>
<sec id="sec014">
<title>M.2 Markov Chain Monte Carlo (MCMC)</title>
<p>To fit the ODE model to data, we generated a likelihood function which we then optimised using MCMC. Specifically, adding Negative Binomial noise to the ODEs describing the model enabled us to calculate a likelihood function for observing the data given our model parameters. This is based on the probability that the deviation between our model and the data can be explained by noise. For each of the four data streams we constructed a likelihood function, which were then multiplied together to build the overall likelihood function. In addition, we included an informative prior for the probability of dying in ICU, <italic>p</italic><sub><italic>D</italic></sub>, giving an overall likelihood function:
<disp-formula id="pcbi.1010406.e021">
<alternatives>
<graphic id="pcbi.1010406.e021g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e021" xlink:type="simple"/>
<mml:math display="block" id="M21">
<mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e022">
<alternatives>
<graphic id="pcbi.1010406.e022g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e022" xlink:type="simple"/>
<mml:math display="block" id="M22">
<mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e023">
<alternatives>
<graphic id="pcbi.1010406.e023g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e023" xlink:type="simple"/>
<mml:math display="block" id="M23">
<mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e024">
<alternatives>
<graphic id="pcbi.1010406.e024g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e024" xlink:type="simple"/>
<mml:math display="block" id="M24">
<mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e025">
<alternatives>
<graphic id="pcbi.1010406.e025g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e025" xlink:type="simple"/>
<mml:math display="block" id="M25">
<mml:mo>−</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mi>π</mml:mi><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac>
</mml:math>
</alternatives>
</disp-formula></p>
<p>Where <italic>A</italic>, <italic>B</italic>, <italic>C</italic> and <italic>D</italic> refer to the four different data streams fitted and σ is the overdispersion parameter of the Negative Binomial observation noise, <italic>d</italic> is the data, <italic>y</italic> is the solution to the ODEs, μ<sub>prior</sub> is the mean prior estimate of <italic>p</italic><sub><italic>D</italic></sub> and σ<sub>prior</sub> is the standard deviation of the prior <italic>p</italic><sub><italic>D</italic></sub> estimate. The continuous variables <italic>y</italic> are defined as
<disp-formula id="pcbi.1010406.e026">
<alternatives>
<graphic id="pcbi.1010406.e026g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e026" xlink:type="simple"/>
<mml:math display="block" id="M26">
<mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e027">
<alternatives>
<graphic id="pcbi.1010406.e027g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e027" xlink:type="simple"/>
<mml:math display="block" id="M27">
<mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e028">
<alternatives>
<graphic id="pcbi.1010406.e028g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e028" xlink:type="simple"/>
<mml:math display="block" id="M28">
<mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1010406.e029">
<alternatives>
<graphic id="pcbi.1010406.e029g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1010406.e029" xlink:type="simple"/>
<mml:math display="block" id="M29">
<mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub>
</mml:math>
</alternatives>
</disp-formula>
and were evaluated at each day for which a data point <italic>d</italic> was available. The sums are over all days for which data is available. Adding an informative prior for <italic>p</italic><sub><italic>D</italic></sub> was required to constrain the values for <italic>p</italic><sub><italic>C</italic></sub> and <italic>p</italic><sub><italic>T</italic></sub>.</p>
<p>To fit the model, we manually tuned a random walk MCMC algorithm implemented in Julia, with the input data depending on whether the first wave or second wave was being fitted. We start the epidemic on 20<sup>th</sup> January 2020, with <italic>I</italic><sub><italic>0</italic></sub> initial cases in the <italic>E</italic><sub><italic>A</italic></sub> and <italic>E</italic><sub><italic>S</italic></sub> states. This allowed sufficient time for the other compartments to reach roughly stable proportions before the first data point on 1<sup>st</sup> March 2020. Prior values for EpiBeds parameters are specified as described in Sections SM.1.3.1 –SM.1.3.2 in <xref ref-type="supplementary-material" rid="pcbi.1010406.s001">S1 Supplementary Material</xref>, coupled with initial conditions for the free parameters with uninformative priors. The ODE was then solved for the input parameters, generating the time-series output that are added to the likelihood functions. Based on these likelihoods, the parameter values are scored and resampled, allowing EpiBeds to explore the parameter space. Code for simulating EpiBeds, and generating the scenarios shown in the paper, are available at [<xref ref-type="bibr" rid="pcbi.1010406.ref011">11</xref>], along with trace plots for all MCMC results included in this paper. Unfortunately, input data cannot be shared, since this was provided through a data sharing agreement, but similar publicly available data are available at [<xref ref-type="bibr" rid="pcbi.1010406.ref002">2</xref>].</p>
<p>When fitting the data, we considered the first and second waves separately. Due to changes in length of stay and patient outcomes over time, we cannot fit a single set of parameters over the whole pandemic. To fit the first wave of the epidemic, we used all four data streams, using data starting on 1<sup>st</sup> March 2020. When fitting the second wave, we removed beds, ICU, and deaths data prior to 1<sup>st</sup> August 2020. Prior to this date, EpiBeds is only constrained by the hospital admissions data, and only the first term of the likelihood (which does not depend on the outcome probabilities <italic>p</italic><sub><italic>C</italic></sub>, <italic>p</italic><sub><italic>T</italic></sub> and <italic>p</italic><sub><italic>D</italic></sub>) is used. After 1<sup>st</sup> August 2020, we introduce the other three data streams and compute the other likelihood terms. This then constrains the probabilities to fit the relationship between these data streams in the second wave.</p>
</sec>
</sec>
<sec id="sec015" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="pcbi.1010406.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.s001" xlink:type="simple">
<label>S1 Supplementary Material</label>
<caption>
<title>Additional details describing the methods for EpiBeds.</title>
<p>Extra figures supporting the narrative. Additional results detailing the input parameters used for the performance evaluation.</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank colleagues in SPI-M-O and JUNIPER consortium for various discussions around hospital modelling and forecasting.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1010406.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Littig</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Isken</surname> <given-names>MW</given-names></name>. <article-title>Short term hospital occupancy prediction</article-title>. <source>Health Care Manage Sci</source>. <year>2007</year> <month>Jan</month> <day>2</day>;<volume>10</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10729-006-9000-9" xlink:type="simple">10.1007/s10729-006-9000-9</ext-link></comment> <object-id pub-id-type="pmid">17323654</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whitt</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>. <article-title>Forecasting arrivals and occupancy levels in an emergency department</article-title>. <source>Operations Research for Health Care</source>. <year>2019</year> <month>Jun</month> <day>1</day>;<volume>21</volume>:<fpage>1</fpage>–<lpage>18</lpage>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leclerc</surname> <given-names>QJ</given-names></name>, <name name-style="western"><surname>Fuller</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Keogh</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Diaz-Ordaz</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sekula</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Semple</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. <article-title>Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England</article-title>. <source>BMC Health Serv Res</source>. <year>2021</year> <month>Jun</month> <day>9</day>;<volume>21</volume>(<issue>1</issue>):<fpage>566</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12913-021-06509-x" xlink:type="simple">10.1186/s12913-021-06509-x</ext-link></comment> <object-id pub-id-type="pmid">34107928</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Donnelly</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hollingsworth</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Keeling</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Vegvari</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Baggaley</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Reproduction number (R) and growth rate (r) of the COVID-19 epidemic in the UK: methods of estimation, data sources, causes of heterogeneity, and use as a guide in policy formulation</article-title>. <source>The Royal Society</source>. <year>2020</year>;<volume>2020</volume>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Funk</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Abbott</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Atkins</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Baguelin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Baillie</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Birrell</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Short-term forecasts to inform the response to the Covid-19 epidemic in the UK</article-title>. <source>medRxiv preprint—BMJ Yale</source> [Internet]. <year>2020</year> <month>Dec</month> <day>4</day> [cited 2021 Sep 10]; Available from: <ext-link ext-link-type="uri" xlink:href="https://researchonline.lshtm.ac.uk/id/eprint/4660335/" xlink:type="simple">https://researchonline.lshtm.ac.uk/id/eprint/4660335/</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref006"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Pellis L, Birrell PJ, Blake J, Overton CE, Scarabel F, Stage HB, et al. Estimation of reproduction numbers in real time: conceptual and statistical challenges. Journal of the Royal Statistical Society Series A. (to appear).</mixed-citation></ref>
<ref id="pcbi.1010406.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>ECDC</collab>. <source>COVID-19 surveillance report Week 25, 2020</source> [Internet]. <year>2020</year> [cited 2021 Sep 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://covid19-surveillance-report.ecdc.europa.eu/" xlink:type="simple">https://covid19-surveillance-report.ecdc.europa.eu/</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>ISARIC</collab>. <source>ISARIC COVID-19 Report: 08 June 2020</source> [Internet]. <year>2020</year> [cited 2021 Sep 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://isaric.tghn.org/" xlink:type="simple">https://isaric.tghn.org/</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref009"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Coronavirus modelling [Internet]. Norwegian Institute of Public Health. [cited 2021 Sep 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.fhi.no/en/id/infectious-diseases/coronavirus/coronavirus-modelling-at-the-niph-fhi/" xlink:type="simple">https://www.fhi.no/en/id/infectious-diseases/coronavirus/coronavirus-modelling-at-the-niph-fhi/</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bhatraju</surname> <given-names>PK</given-names></name>, <name name-style="western"><surname>Ghassemieh</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Jerome</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Nalla</surname> <given-names>AK</given-names></name>, <etal>et al</etal>. <article-title>Covid-19 in Critically Ill Patients in the Seattle Region—Case Series</article-title>. <source>New England Journal of Medicine</source>. <year>2020</year> <month>May</month> <day>21</day>;<volume>382</volume>(<issue>21</issue>):<fpage>2012</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa2004500" xlink:type="simple">10.1056/NEJMoa2004500</ext-link></comment> <object-id pub-id-type="pmid">32227758</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>ICNARC</collab>. <source>ICNARC report on COVID-19 in critical care 17 July 2020</source> [Internet]. <year>2020</year> [cited 2021 Sep 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports" xlink:type="simple">https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Petrilli</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rajagopalan</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>O’Donnell</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chernyak</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study</article-title>. <source>BMJ</source>. <year>2020</year> <month>May</month> <day>22</day>;<volume>369</volume>:<fpage>m1966</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.m1966" xlink:type="simple">10.1136/bmj.m1966</ext-link></comment> <object-id pub-id-type="pmid">32444366</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grasselli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Zangrillo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Zanella</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Antonelli</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cabrini</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Castelli</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy</article-title>. <source>Jama</source>. <year>2020</year>;<volume>323</volume>(<issue>16</issue>):<fpage>1574</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.2020.5394" xlink:type="simple">10.1001/jama.2020.5394</ext-link></comment> <object-id pub-id-type="pmid">32250385</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lewnard</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>VX</given-names></name>, <name name-style="western"><surname>Jackson</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Jewell</surname> <given-names>BL</given-names></name>, <name name-style="western"><surname>Flores</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study</article-title>. <source>BMJ</source>. <year>2020</year> <month>May</month> <day>22</day>;<volume>369</volume>:<fpage>m1923</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.m1923" xlink:type="simple">10.1136/bmj.m1923</ext-link></comment> <object-id pub-id-type="pmid">32444358</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saito</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Asai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Matsunaga</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hayakawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Terada</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ohtsu</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics</article-title>. <source>Journal of Infection</source>. <year>2021</year> <month>Apr</month> <day>1</day>;<volume>82</volume>(<issue>4</issue>):<fpage>84</fpage>–<lpage>123</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jinf.2020.10.033" xlink:type="simple">10.1016/j.jinf.2020.10.033</ext-link></comment> <object-id pub-id-type="pmid">33152376</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iftimie</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>López-Azcona</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Vallverdú</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hernández-Flix</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>De Febrer</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Parra</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain</article-title>. <source>PloS one</source>. <year>2021</year>;<volume>16</volume>(<issue>3</issue>):<fpage>e0248029</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0248029" xlink:type="simple">10.1371/journal.pone.0248029</ext-link></comment> <object-id pub-id-type="pmid">33788866</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vogel</surname> <given-names>T.</given-names></name> <article-title>Théorie des systèmes évolutifs</article-title>. Vol. <volume>22</volume>. <source>Gauthier-Villars</source>; <year>1965</year>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pellis</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Scarabel</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Stage</surname> <given-names>HB</given-names></name>, <name name-style="western"><surname>Overton</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Chappell</surname> <given-names>LHK</given-names></name>, <name name-style="western"><surname>Fearon</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Challenges in control of COVID-19: short doubling time and long delay to effect of interventions</article-title>. <source>Philosophical Transactions of the Royal Society B: Biological Sciences</source>. <year>2021</year> <month>Jul</month> <day>19</day>;<volume>376</volume>(<issue>1829</issue>):<fpage>20200264</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1098/rstb.2020.0264" xlink:type="simple">10.1098/rstb.2020.0264</ext-link></comment> <object-id pub-id-type="pmid">34053267</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ashcroft</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Huisman</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Lehtinen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bouman</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Althaus</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Regoes</surname> <given-names>RR</given-names></name>, <etal>et al</etal>. <article-title>COVID-19 infectivity profile correction</article-title>. <source>arXiv preprint arXiv:200706602</source>. <year>2020</year>; <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4414/smw.2020.20336" xlink:type="simple">10.4414/smw.2020.20336</ext-link></comment> <object-id pub-id-type="pmid">32757177</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferretti</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wymant</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kendall</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Nurtay</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Abeler-Dörner</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing</article-title>. <source>Science</source>. <year>2020</year> <month>May</month> <day>8</day>;<volume>368</volume>(<issue>6491</issue>):<fpage>eabb6936</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.abb6936" xlink:type="simple">10.1126/science.abb6936</ext-link></comment> <object-id pub-id-type="pmid">32234805</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref021"><label>21</label><mixed-citation publication-type="book" xlink:type="simple"><collab>FHI COVID-19 modelling team</collab>. <chapter-title>Coronavirus modelling at the NIPH</chapter-title>. <source>Retrieved June 12, 2020</source>. [Internet]. <publisher-name>Norwegian Institute of Public Health</publisher-name>. <year>2020</year> [cited 2021 Sep 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.fhi.no/en/id/infectious-diseases/coronavirus/coronavirus-modelling-at-the-niph-fhi/" xlink:type="simple">https://www.fhi.no/en/id/infectious-diseases/coronavirus/coronavirus-modelling-at-the-niph-fhi/</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salje</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tran Kiem</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lefrancq</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Courtejoie</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Bosetti</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Paireau</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Estimating the burden of SARS-CoV-2 in France</article-title>. <source>Science</source>. <year>2020</year> <month>Jul</month> <day>10</day>;<volume>369</volume>(<issue>6500</issue>):<fpage>208</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.abc3517" xlink:type="simple">10.1126/science.abc3517</ext-link></comment> <object-id pub-id-type="pmid">32404476</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vekaria</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Overton</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wiśniowski</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ahmad</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Aparicio-Castro</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Curran-Sebastian</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning</article-title>. <source>BMC Infectious Diseases</source>. <year>2021</year> <month>Jul</month> <day>22</day>;<volume>21</volume>(<issue>1</issue>):<fpage>700</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12879-021-06371-6" xlink:type="simple">10.1186/s12879-021-06371-6</ext-link></comment> <object-id pub-id-type="pmid">34294037</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davies</surname> <given-names>NG</given-names></name>, <name name-style="western"><surname>Klepac</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Prem</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Jit</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eggo</surname> <given-names>RM</given-names></name>. <article-title>Age-dependent effects in the transmission and control of COVID-19 epidemics</article-title>. <source>Nat Med</source>. <year>2020</year> <month>Aug</month>;<volume>26</volume>(<issue>8</issue>):<fpage>1205</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41591-020-0962-9" xlink:type="simple">10.1038/s41591-020-0962-9</ext-link></comment> <object-id pub-id-type="pmid">32546824</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Mo</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Qi</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China</article-title>. <source>Pediatrics</source>. <year>2020</year>;</mixed-citation></ref>
<ref id="pcbi.1010406.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lavezzo</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Franchin</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Ciavarella</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cuomo-Dannenburg</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Barzon</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Del Vecchio</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’</article-title>. <source>Nature</source>. <year>2020</year> <month>Aug</month>;<volume>584</volume>(<issue>7821</issue>):<fpage>425</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mizumoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kagaya</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zarebski</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chowell</surname> <given-names>G</given-names></name>. <article-title>Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020</article-title>. <source>Eurosurveillance</source>. <year>2020</year> <month>Mar</month> <day>12</day>;<volume>25</volume>(<issue>10</issue>):<fpage>2000180</fpage>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Streeck</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Schulte</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Kümmerer</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Richter</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Höller</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Fuhrmann</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <source>Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event</source> [Internet]. <year>2020</year> <month>Jun</month> [cited 2021 Sep 10] p. 2020.05.04.20090076. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.05.04.20090076v2" xlink:type="simple">https://www.medrxiv.org/content/10.1101/2020.05.04.20090076v2</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riccardo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ajelli</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Andrianou</surname> <given-names>XD</given-names></name>, <name name-style="western"><surname>Bella</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Manso</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Fabiani</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020</article-title>. <source>Eurosurveillance</source>. <year>2020</year> <month>Dec</month> <day>10</day>;<volume>25</volume>(<issue>49</issue>):<fpage>2000790</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2807/1560-7917.ES.2020.25.49.2000790" xlink:type="simple">10.2807/1560-7917.ES.2020.25.49.2000790</ext-link></comment> <object-id pub-id-type="pmid">33303064</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Zhuang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>MH</given-names></name>, <etal>et al</etal>. <article-title>The relative transmissibility of asymptomatic COVID-19 infections among close contacts</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2020</year> <month>May</month> <day>1</day>;<volume>94</volume>:<fpage>145</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijid.2020.04.034" xlink:type="simple">10.1016/j.ijid.2020.04.034</ext-link></comment> <object-id pub-id-type="pmid">32315808</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref031"><label>31</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Luo</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liao</surname> <given-names>X long</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>XB</given-names></name>, <name name-style="western"><surname>Jing</surname> <given-names>Q long</given-names></name>, <name name-style="western"><surname>Zheng</surname> <given-names>J zhen</given-names></name>, <etal>et al</etal>. <source>Modes of Contact and Risk of Transmission in COVID-19: A Prospective Cohort Study 4950 Close Contact Persons in Guangzhou of China [Internet]</source>. <publisher-loc>Rochester, NY</publisher-loc>: <publisher-name>Social Science Research Network</publisher-name>; <year>2020</year> <month>Mar</month> [cited 2021 Sep 10]. Report No.: ID 3566149. Available from: <ext-link ext-link-type="uri" xlink:href="https://papers.ssrn.com/abstract=3566149" xlink:type="simple">https://papers.ssrn.com/abstract=3566149</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Illingworth</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Hamilton</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Warne</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Routledge</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Popay</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jackson</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections</article-title>. <name name-style="western"><surname>Walczak</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Ogbunugafor</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Cobey</surname> <given-names>SE</given-names></name>, editors. <source>eLife</source>. <year>2021</year> <month>Aug</month> <day>24</day>;<volume>10</volume>:<fpage>e67308</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.67308" xlink:type="simple">10.7554/eLife.67308</ext-link></comment> <object-id pub-id-type="pmid">34425938</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref033"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Overton CE. EpiBeds [Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/OvertonC/EpiBeds" xlink:type="simple">https://github.com/OvertonC/EpiBeds</ext-link>.</mixed-citation></ref>
<ref id="pcbi.1010406.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davies</surname> <given-names>NG</given-names></name>, <name name-style="western"><surname>Abbott</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Barnard</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Jarvis</surname> <given-names>CI</given-names></name>, <name name-style="western"><surname>Kucharski</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Munday</surname> <given-names>JD</given-names></name>, <etal>et al</etal>. <article-title>Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England</article-title>. <source>Science</source>. <year>2021</year> <month>Apr</month> <day>9</day>;<volume>372</volume>(<issue>6538</issue>):<fpage>eabg3055</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.abg3055" xlink:type="simple">10.1126/science.abg3055</ext-link></comment> <object-id pub-id-type="pmid">33658326</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dehning</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zierenberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Spitzner</surname> <given-names>FP</given-names></name>, <name name-style="western"><surname>Wibral</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Neto</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Wilczek</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions</article-title>. <source>Science</source>. <year>2020</year> <month>Jul</month> <day>10</day>;<volume>369</volume>(<issue>6500</issue>):<fpage>eabb9789</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.abb9789" xlink:type="simple">10.1126/science.abb9789</ext-link></comment> <object-id pub-id-type="pmid">32414780</object-id></mixed-citation></ref>
<ref id="pcbi.1010406.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williamson</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Bhaskaran</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bacon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bates</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Morton</surname> <given-names>CE</given-names></name>, <etal>et al</etal>. <article-title>Factors associated with COVID-19-related death using OpenSAFELY</article-title>. <source>Nature</source>. <year>2020</year> <month>Aug</month>;<volume>584</volume>(<issue>7821</issue>):<fpage>430</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41586-020-2521-4" xlink:type="simple">10.1038/s41586-020-2521-4</ext-link></comment> <object-id pub-id-type="pmid">32640463</object-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article article-type="aggregated-review-documents" id="pcbi.1010406.r001" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1010406.r001</article-id>
<title-group>
<article-title>Decision Letter 0</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Pitzer</surname>
<given-names>Virginia E.</given-names>
</name>
<role>Deputy Editor-in-Chief</role>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Struchiner</surname>
<given-names>Claudio José</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Pitzer, Struchiner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pcbi.1010406" document-id-type="doi" document-type="article" id="rel-obj001" link-type="peer-reviewed-article"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>0</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">4 Feb 2022</named-content>
</p>
<p>Dear Dr Overton,</p>
<p>Thank you very much for submitting your manuscript "EpiBeds: Data informed modelling of the COVID-19 hospital burden in England" for consideration at PLOS Computational Biology.</p>
<p>As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.</p>
<p>We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.</p>
<p>When you are ready to resubmit, please upload the following:</p>
<p>[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
<p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p>
<p>Important additional instructions are given below your reviewer comments.</p>
<p>Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.</p>
<p>Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
<p>Sincerely,</p>
<p>Claudio José Struchiner, M.D., Sc.D.</p>
<p>Associate Editor</p>
<p>PLOS Computational Biology</p>
<p>Virginia Pitzer</p>
<p>Deputy Editor-in-Chief</p>
<p>PLOS Computational Biology</p>
<p>***********************</p>
<p>Reviewer's Responses to Questions</p>
<p><bold>Comments to the Authors:</bold></p>
<p><bold>Please note here if the review is uploaded as an attachment.</bold></p>
<p>Reviewer #1: The summary of my review and comments addressed to authors are uploaded as an attachment.</p>
<p>Reviewer #2: Review of the manuscript 'EpiBeds: Data informed modelling of the COVID-19 hospital burden in England' by Christopher Overton and colleagues, submitted to PLOS Computational Biology.</p>
<p>Summary</p>
<p>In this manuscript, Overton and colleagues fit a transmission model for SARS-CoV-2 in England together with a hospital progression model to national-level data on hospital admissions, hospital occupancy (including ICUs), length of stay distributions in the hospital and in the intensive care, and hospital discharge and death data. Main goal is to obtain estimates of the durations in the various compartments in hospitals in England. The authors argue that the main value of the model is that has provided weekly forecasts of bed occupancy and admissions during the early stage of SARS-CoV-2 pandemic, and in addition suggest that the model is easily be adapted to apply to different pathogens and countries.</p>
<p>Evaluation</p>
<p>Overall, the methods are laid out clearly, the model code is publicly available, and I have no doubt that the analyses are sound. Also, I believe that the analyses may have helped the English government and public health bodies to anticipate hospital demand. I do have some reservations as to what the scientific novelty is of the analyses presented in the manuscript is. It is true that the within-hospital progression model is somewhat more complex than most (perhaps all) other transmission models that have been fitted to hospital data, but many aspects that could have made this manuscript stand out are missing. For instance, (1) all analyses are performed for national level data and as far as I can see no attempt has been made to include analyses at the regional of hospital level. This is unfortunate as the national-level data are the resultant of the superposition of local epidemics. (2) As far as I can see no attempt has been made to analyze and fit age-stratified models to age-stratified data, even though it is known that hospitalization rates are strongly age-dependent while age-stratified incidence has also changed quite a bit during the pandemic. This problem is now partially solved by defining different periods for the analyses, but it would have been nice if everything would have been fitted in one go with an age-stratified transmission model. (3) Hardly any formal (in the statistical sense) effort been undertaken to evaluate predictive performance of the model (e.g., using leave-one-out cross-validation), and I did not spot any formal attempt of model selection. In essence, the authors use a single model and rely on visualizations to spot where data and model are congruent. In all, I do not suggest that the authors should actually address the above points by adding more models and analyses, but it does lessen my enthusiasm for the manuscript. I suggest the authors put more effort in a critical evaluation of their model in the discussion, and perhaps could add something on cross-validation and model selection in the main analyses.</p>
<p>Specific comments/suggestions</p>
<p>-intro, second paragraph. please add that assessment of the current situation (i.e nowcasting) is a problem in itself. Also add in the discussion how your results are affected if cases (by admission date) are only complete after some time (two weeks? is this a problem?)</p>
<p>-Figure 1. I found this figure not very appealing visually, and the legend difficult to follow.</p>
<p>-"With the foresight of formulating ...". It is of course quite convenient that delay distributions are apparently well-described by exponential distributions. It is, however, not difficult to rewrite the model from the hospital compartment (L_H) onwards in terms of delay equations. Please discuss and elaborate in the Discussion.</p>
<p>-Figure 2. I found this somewhat superfluous, especially the distinction between i. and ii.</p>
<p>-"The structure for the generalised ...". Please mention once that formally these are a specific class of exponential distributions, i.e. Erlang distributions.</p>
<p>-"This level of accuracy is sufficient since ...". This strikes me as an unwarranted claim. Please remoce or explain in detail.</p>
<p>-Section 2.3.1. Please provide rationale WHY most parameters are fixed while only a small number is estimated. Especially, as in the Bayesian context you have the flexibility to add (weakly) informative priors. Why did you include a highly informative prior for p_D but not for the other p parameters?</p>
<p>-Figure 4, bottom left. There is a systematic deviation from the posterior median. Explain in intuitive terms? Also, are bands actual Bayesian prediction intervals, or CrIs?</p>
<p>**********</p>
<p><bold>Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?</bold></p>
<p>The <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/materials-and-software-sharing" xlink:type="simple">PLOS Data policy</ext-link> requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: None</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history" xlink:type="simple">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy" xlink:type="simple">Privacy Policy</ext-link>.</p>
<p>Reviewer #1: <bold>Yes: </bold>Quentin J Leclerc</p>
<p>Reviewer #2: No</p>
<p><underline>Figure Files:</underline></p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <underline><ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/" xlink:type="simple">https://pacev2.apexcovantage.com</ext-link></underline>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <underline><email xlink:type="simple">figures@plos.org</email></underline>.</p>
<p><underline>Data Requirements:</underline></p>
<p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: <ext-link ext-link-type="uri" xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5" xlink:type="simple">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p>
<p><underline>Reproducibility:</underline></p>
<p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link ext-link-type="uri" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" xlink:type="simple">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
<supplementary-material id="pcbi.1010406.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.s002" xlink:type="simple">
<label>Attachment</label>
<caption>
<p>Submitted filename: <named-content content-type="submitted-filename">EpiBeds review.docx</named-content></p>
</caption>
</supplementary-material>
</body>
</sub-article>
<sub-article article-type="author-comment" id="pcbi.1010406.r002">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1010406.r002</article-id>
<title-group>
<article-title>Author response to Decision Letter 0</article-title>
</title-group>
<related-object document-id="10.1371/journal.pcbi.1010406" document-id-type="doi" document-type="peer-reviewed-article" id="rel-obj002" link-type="rebutted-decision-letter" object-id="10.1371/journal.pcbi.1010406.r001" object-id-type="doi" object-type="decision-letter"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="author-response-date">15 Jun 2022</named-content>
</p>
<supplementary-material id="pcbi.1010406.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1010406.s003" xlink:type="simple">
<label>Attachment</label>
<caption>
<p>Submitted filename: <named-content content-type="submitted-filename">Epibeds response to reviewers.docx</named-content></p>
</caption>
</supplementary-material>
</body>
</sub-article>
<sub-article article-type="aggregated-review-documents" id="pcbi.1010406.r003" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1010406.r003</article-id>
<title-group>
<article-title>Decision Letter 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Pitzer</surname>
<given-names>Virginia E.</given-names>
</name>
<role>Deputy Editor-in-Chief</role>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Struchiner</surname>
<given-names>Claudio José</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Pitzer, Struchiner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pcbi.1010406" document-id-type="doi" document-type="article" id="rel-obj003" link-type="peer-reviewed-article"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">18 Jul 2022</named-content>
</p>
<p>Dear Dr Overton,</p>
<p>We are pleased to inform you that your manuscript 'EpiBeds: Data informed modelling of the COVID-19 hospital burden in England' has been provisionally accepted for publication in PLOS Computational Biology.</p>
<p>Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.</p>
<p>Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.</p>
<p>IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.</p>
<p>Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.</p>
<p>Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. </p>
<p>Best regards,</p>
<p>Claudio José Struchiner, M.D., Sc.D.</p>
<p>Associate Editor</p>
<p>PLOS Computational Biology</p>
<p>Virginia Pitzer</p>
<p>Deputy Editor-in-Chief</p>
<p>PLOS Computational Biology</p>
<p>***********************************************************</p>
<p>Reviewer's Responses to Questions</p>
<p><bold>Comments to the Authors:</bold></p>
<p><bold>Please note here if the review is uploaded as an attachment.</bold></p>
<p>Reviewer #1: I would like to congratulate the authors again for this interesting work, and am glad they found my comments useful. I am happy with the revisions made to the manuscript. The paper is now much more streamlined and easier to read. I do not have any further comments or suggestions for the authors.</p>
<p>**********</p>
<p><bold>Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?</bold></p>
<p>The <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/materials-and-software-sharing" xlink:type="simple">PLOS Data policy</ext-link> requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: None</p>
<p>**********</p>
<p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history" xlink:type="simple">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy" xlink:type="simple">Privacy Policy</ext-link>.</p>
<p>Reviewer #1: <bold>Yes: </bold>Quentin J Leclerc</p>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pcbi.1010406.r004" specific-use="acceptance-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1010406.r004</article-id>
<title-group>
<article-title>Acceptance letter</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Pitzer</surname>
<given-names>Virginia E.</given-names>
</name>
<role>Deputy Editor-in-Chief</role>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Struchiner</surname>
<given-names>Claudio José</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Pitzer, Struchiner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pcbi.1010406" document-id-type="doi" document-type="article" id="rel-obj004" link-type="peer-reviewed-article"/>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">31 Aug 2022</named-content>
</p>
<p>PCOMPBIOL-D-21-02185R1 </p>
<p>EpiBeds: Data informed modelling of the COVID-19 hospital burden in England</p>
<p>Dear Dr Overton,</p>
<p>I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
<p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
<p>Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
<p>Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! </p>
<p>With kind regards,</p>
<p>Anita Estes</p>
<p>PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom <email xlink:type="simple">ploscompbiol@plos.org</email> | Phone +44 (0) 1223-442824 | <ext-link ext-link-type="uri" xlink:href="http://ploscompbiol.org" xlink:type="simple">ploscompbiol.org</ext-link> | @PLOSCompBiol</p>
</body>
</sub-article>
</article>